tiprankstipranks
Trending News
More News >
GenSight Biologics SA (FR:SIGHT)
:SIGHT
France Market

GenSight Biologics SA (SIGHT) Technical Analysis

Compare
3 Followers

Summary of all the Indicators

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
GenSight Biologics SA’s (SIGHT) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting GenSight Biologics SA is a Buy.
GenSight Biologics SA’s (SIGHT) 20-Day exponential moving average is 0.09, while GenSight Biologics SA’s (SIGHT) share price is <€0.1, making it a Sell.
GenSight Biologics SA’s (SIGHT) 50-Day exponential moving average is 0.10, while GenSight Biologics SA’s (SIGHT) share price is <€0.1, making it a Sell.

GenSight Biologics SA (SIGHT) Pivot Points

Jan 31, 2026, 01:37 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.07
0.08
0.08
0.08
0.08
0.09
0.09
Fibonacci
0.08
0.08
0.08
0.08
0.08
0.09
0.09
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

GenSight Biologics SA (SIGHT) Moving Averages

Jan 31, 2026, 01:37 PM
Period
Simple
Exponential
MA5
0.08Buy
0.08Sell
MA10
0.08Sell
0.08Sell
MA20
0.09Sell
0.09Sell
MA50
0.10Sell
0.10Sell
MA100
0.12Sell
0.12Sell
MA200
0.15Sell
0.15Sell
GenSight Biologics SA’s (SIGHT) 10-Day exponential moving average is 0.08, while GenSight Biologics SA’s (SIGHT) share price is <€0.1, making it a Sell.
GenSight Biologics SA’s (SIGHT) 100-Day exponential moving average is 0.12, while GenSight Biologics SA’s (SIGHT) share price is <€0.1, making it a Sell.
GenSight Biologics SA’s (SIGHT) stock price is <€0.1 and GenSight Biologics SA’s (SIGHT) 50-day simple moving average is 0.10, creating a Sell signal.
GenSight Biologics SA’s (SIGHT) stock price is <€0.1 and GenSight Biologics SA’s (SIGHT) 100-day simple moving average is 0.12, creating a Sell signal.
GenSight Biologics SA’s (SIGHT) stock price is <€0.1 and GenSight Biologics SA’s (SIGHT) 200-day simple moving average is 0.15, creating a Sell signal.

GenSight Biologics SA (SIGHT) Technical Indicators

Jan 31, 2026, 01:37 PM
Name
Value
Implied Action
RSI (14)
38.47
Neutral
STOCH (9,6)
24.92
Neutral
STOCHRSI (14)
15.09
Buy
MACD (12,26)
>-0.01
Buy
ADX (14)
35.25
Neutral
Williams %R
-74.07
Buy
CCI (14)
-95.91
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
31.27
Neutral
ROC
-17.17
Sell
GenSight Biologics SA’s (SIGHT) Relative Strength Index (RSI) is 38.47, creating a Neutral signal.
GenSight Biologics SA’s (SIGHT) Trend Strength Indicator (ADX) is 35.25, creating a Neutral signal.
GenSight Biologics SA’s (SIGHT) Commodity Channel Index (CCI) is -95.91, creating a Neutral signal.
GenSight Biologics SA’s (SIGHT) Price Rate of Change (ROC) is -17.17, creating a Sell signal.

FAQ

Is SIGHT a Buy, Hold, or Sell?
Based on SIGHT’s technical indicators, SIGHT is a Sell.
    What is SIGHT’s RSI (14)?
    SIGHT’s RSI (14) is 38.47, which suggests SIGHT is a Neutral.
      What is SIGHT’s MACD?
      SIGHT’s MACD is >-0.01, which suggests SIGHT is a Buy.
        What is SIGHT’s 5-day moving average?
        SIGHT’s 5-day moving average is 0.08, which suggests SIGHT is a Buy.
          What is SIGHT’s 20-day moving average?
          SIGHT 20-day moving average is 0.09, which suggests SIGHT is a Sell.
            What is SIGHT’s 50-day moving average?
            SIGHT’s 50-day moving average is 0.10, which suggests SIGHT is a Sell.
              What is SIGHT’s 200-day moving average?
              SIGHT’s 200-day moving average is 0.15, which suggests SIGHT is a Sell.
                What is SIGHT’s Williams % R (14)?
                SIGHT’s Williams % R (14) is -74.07, which suggests SIGHT is a Buy.
                  What is SIGHT’s CCI (14)?
                  SIGHT’s CCI (14) is -95.91, which suggests SIGHT is a Neutral.
                    What is the share price of GenSight Biologics SA?